Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Derek A Wainwright

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Brain, Behavior, & Immunity - Health|April 11, 2024
Age-stratified comorbid and pharmacologic analysis of patients with glioblastomaErik E Rabin, Jonathan Huang, Miri Kim, et al.
Cell Reports|November 3, 2021
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drugJunfeng Bi, Atif Khan, Jun Tang, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Rational Design and Optimization of a Potent IDO1 Proteolysis Targeting Chimera (PROTAC)Paige J Monsen, Prashant V Bommi, Arabela A Grigorescu, et al.
Journal of Medicinal Chemistry|February 13, 2025
Rational Design and Optimization of a Potent IDO1 Proteolysis Targeting Chimera (PROTAC)Paige J Monsen, Prashant V Bommi, Arabela A Grigorescu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with GlioblastomaErik Ladomersky, Lijie Zhai, Kristen L Lauing, et al.
Journal of Medicinal Chemistry|November 21, 2022
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for GlioblastomaLakshmi R Bollu, Prashant V Bommi, Paige J Monsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2023
Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral InfluenceMargaret Johnson, April Bell, Kristen L Lauing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205Rimas V Lukas, Lijie Zhai, Kristen L Lauing, et al.
Neuro-Oncology Advances|October 14, 2021
Glioblastoma as an age-related neurological disorder in adultsMiri Kim, Erik Ladomersky, Andreas Mozny, et al.
Neuro-Oncology|December 28, 2020
Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think TankPavlina Chuntova, Frances Chow, Payal B Watchmaker, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Brain, Behavior, & Immunity - Health|April 11, 2024
Age-stratified comorbid and pharmacologic analysis of patients with glioblastomaErik E Rabin, Jonathan Huang, Miri Kim, et al.
Cell Reports|November 3, 2021
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drugJunfeng Bi, Atif Khan, Jun Tang, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Rational Design and Optimization of a Potent IDO1 Proteolysis Targeting Chimera (PROTAC)Paige J Monsen, Prashant V Bommi, Arabela A Grigorescu, et al.
Journal of Medicinal Chemistry|February 13, 2025
Rational Design and Optimization of a Potent IDO1 Proteolysis Targeting Chimera (PROTAC)Paige J Monsen, Prashant V Bommi, Arabela A Grigorescu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with GlioblastomaErik Ladomersky, Lijie Zhai, Kristen L Lauing, et al.
Journal of Medicinal Chemistry|November 21, 2022
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for GlioblastomaLakshmi R Bollu, Prashant V Bommi, Paige J Monsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2023
Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral InfluenceMargaret Johnson, April Bell, Kristen L Lauing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205Rimas V Lukas, Lijie Zhai, Kristen L Lauing, et al.
Neuro-Oncology Advances|October 14, 2021
Glioblastoma as an age-related neurological disorder in adultsMiri Kim, Erik Ladomersky, Andreas Mozny, et al.
Neuro-Oncology|December 28, 2020
Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think TankPavlina Chuntova, Frances Chow, Payal B Watchmaker, et al.
Pageof 9